Sep 8, 2020
Publication
0 Views
News
An Alzheimer’s Challenge Big Pharma Couldn’t Solve — Addressed Through Industry–Academia Collaboration
IMNEWRUN Leading Brain Disease Solutions with TRANSMAB® Opening New Horizons in Advanced Neuroscience through Integrated Brain Research and Innovative Technologies